TrialBreast cancer research and treatment2014

TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases.

Carey Anders et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.